MARTYN D GREENACRE

CIK 1209727 · last filed 2026-07-09

MARTYN D GREENACRE is a corporate insider who has filed 59 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for CRIS, was dated Jul 9, 2026. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $314 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$314

Companies

7

Total Filings

59

Lifetime Open-Market Net

-$3.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRIS Director 65 $4.83 $314 -$874.1K 27 2026-07-09
LISATA THERAPEUTICS, INC. (NBS) Delisted Director 88,531 $0 4 2015-06-04
LISATA THERAPEUTICS, INC. (NBS.WS) Delisted Director 755,306 $0 3 2012-07-03
CEPHALON INC (CEPH) Delisted Director 10,000 -$3.03M 11 2011-10-17
BMP Sunstone CORP (BJGP) Delisted Director 17,800 $19.8K 6 2009-08-17
ACUSPHERE INC (ACUS) Delisted Director 135,062 $25.7K 6 2009-01-06
ORCHESTRA THERAPEUTICS, INC. (FLE) Delisted Director $0 1 2007-04-30

Recent Filings

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-09 CRIS Grant (A) $0 EDGAR
2025-05-22 CRIS Grant (A) $0 EDGAR
2025-01-30 CRIS Grant (A) $0 EDGAR
2024-05-23 CRIS Grant (A) $0 EDGAR
2023-01-24 CRIS Grant (A) $0 EDGAR
2022-01-31 CRIS Grant (A) $0 EDGAR
2021-01-29 CRIS Grant (A) $0 EDGAR
2020-03-04 CRIS Grant (A) $0 EDGAR
2019-01-25 CRIS Sell (S) −18,500 -$19.5K EDGAR
2019-01-23 CRIS Grant (A) $0 EDGAR
Showing 110 of 59
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.